These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2901561)

  • 1. Blood group substances in pneumococcal vaccine.
    Nalin DR; Morges W
    Lancet; 1988 Sep; 2(8612):695. PubMed ID: 2901561
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood group A substances are not present in currently available pneumococcal vaccine.
    Nalin DR; Morges W
    Vaccine; 1988 Dec; 6(6):469-70. PubMed ID: 3245290
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenic protein contaminants in pneumococcal vaccines.
    Yu J; Briles DE; Englund JA; Hollingshead SK; Glezen WP; Nahm MH
    J Infect Dis; 2003 Mar; 187(6):1019-23. PubMed ID: 12660950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-group-A-like substance in a preparation of pneumococcal vaccine.
    Siber GR; Ambrosino DM; Gorgone BC
    Ann Intern Med; 1982 May; 96(5):580-6. PubMed ID: 7073150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal polysaccharide antigens: capsules and C-polysaccharide. An immunochemical study.
    Sørensen UB
    Dan Med Bull; 1995 Feb; 42(1):47-53. PubMed ID: 7729169
    [No Abstract]   [Full Text] [Related]  

  • 6. Pneumococcal serotype distribution and vaccine relevance.
    Martin DR; Campbell-Redl CV
    N Z Med J; 1984 Jan; 97(748):53. PubMed ID: 6582411
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative analysis of 23-valent 'Pneumovax' by automated rate nephelometry.
    Salerno RA; Odell C; McCauley J; Mancinelli R; Morges W; Gray A
    J Biol Stand; 1984 Oct; 12(4):447-50. PubMed ID: 6526829
    [No Abstract]   [Full Text] [Related]  

  • 8. New vaccine targets childhood pneumonia.
    Stephenson J
    JAMA; 1999 Nov; 282(20):1905. PubMed ID: 10580443
    [No Abstract]   [Full Text] [Related]  

  • 9. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
    Anttila M; Eskola J; Ahman H; Käyhty H
    J Infect Dis; 1998 Jun; 177(6):1614-21. PubMed ID: 9607841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal vaccine.
    Lipsky BA; Hirschmann JV
    N Engl J Med; 1984 Jul; 311(4):260-1. PubMed ID: 6738628
    [No Abstract]   [Full Text] [Related]  

  • 11. Pneumococcal vaccine.
    JAMA; 1991 May; 265(17):2193-4. PubMed ID: 2013949
    [No Abstract]   [Full Text] [Related]  

  • 12. When to use the new pneumococcal vaccine.
    Drug Ther Bull; 1990 Apr; 28(8):31-2. PubMed ID: 2131247
    [No Abstract]   [Full Text] [Related]  

  • 13. Pneumococcal vaccine--past, present, and future.
    Broome CV; Breiman RF
    N Engl J Med; 1991 Nov; 325(21):1506-8. PubMed ID: 1944428
    [No Abstract]   [Full Text] [Related]  

  • 14. Pneumococcal serotypes causing bacteremia and meningitis: relevance to composition of pneumococcal vaccine.
    Dixon JM; Lipinski AE
    Can Med Assoc J; 1981 Aug; 125(3):263-7. PubMed ID: 7272879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pneumococcal vaccine after 15 years of use.
    Hirschmann JV; Lipsky BA
    Arch Intern Med; 1994 Feb; 154(4):373-7. PubMed ID: 8117169
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pneumococcal vaccine: protection for polysaccharide germs?].
    Cerny A; Mühlemann K
    Schweiz Med Wochenschr; 1995 May; 125(19):949-51. PubMed ID: 7761804
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharma-clinics. Drug of the month. Polyvalent antipneumococcal vaccine (Pneumune)].
    Scheen AJ
    Rev Med Liege; 1996 Mar; 51(3):257-8. PubMed ID: 8668891
    [No Abstract]   [Full Text] [Related]  

  • 18. Pneumococcal vaccine: overcoming barriers to use.
    Tamblyn SE
    CMAJ; 1998 Jan; 158(1):87-8. PubMed ID: 9475917
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppressive effect of pneumococcal vaccine contaminated with blood-group-A-like substance.
    Nurmi T; Koskela P
    Lancet; 1988 Apr; 1(8588):771. PubMed ID: 2895302
    [No Abstract]   [Full Text] [Related]  

  • 20. The current status of polyvalent pneumococcal vaccine.
    Austrian R
    Clin Ther; 1984; 6(5):572-5. PubMed ID: 6383609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.